TFF2 and ependymoma: Of the ten tested immune cell populations, significantly more T cells, CD8 T cells and natural killer (NK cells) were estimated for subtype B. Together, further analysis of the previously identified transcriptional SP-EPN profiles revealed variably enriched gene sets among the subtypes and validated the two subtypes in an independent cohort of 209 ependymoma cases.